Latest Breaking News On - Careggi university hospital - Page 10 : comparemela.com
Medical Microinstruments Symani® Surgical System Saves Patient s Arm from Amputation
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Medical Microinstruments S p A : Medical Microinstruments Symani Surgical System Saves Patient s Arm from Amputation
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Moto3 riderJason Dupasquier has tragically died aged just 19 after suffering a serious crash during qualifying in Mugello, Italy. The Swiss PruestelGP rider was involved in a serious three-bike accident between turns nine and 10 during Qualifying 2 for the Gran Premio d’Italia Oakley on Saturday and was treated on the track with the session red-flagged before being airlifted to Careggi University Hospital in Florence. On Sunday morning, MotoGP.
Apr 27, 2021
Clinical guide green lights point-of-care imaging with standard diagnosis in ED, inpatient settings
Clinicians can use add-on point-of-care ultrasonography in patients with unspecified acute dyspnea in the emergency department (ED) or inpatient setting, according to the American College of Physicians (ACP), although the recommendation is based on a low certainty of evidence.
Combining point-of-care ultrasonography (POCUS) with the standard diagnostic pathway increased the proportion of correct diagnoses by 32%, boosted the sensitivity of standard testing without “a substantial tradeoff in specificity,” did not seem to be tied to any serious harms, is not a high-cost test, and did not result in a longer length of stay (LOS) for patients, wrote Amir Qaseem, MD, PhD, MHA, of the ACP in Philadelphia, and co-authors on the college’s clinical guidelines committee.
E-Mail
A group of scientists have just made a key discovery that could prevent and eradicate immune responses that lead to treatment failure in about one-third of people with severe hemophilia A.
Hemophilia is the most common severe inherited bleeding disorder in men. The disease affects 1 in 10,000 males worldwide and results from deficiency of blood clotting factor VIII (FVIII). Both children and adults with hemophilia A (80 percent of all hemophilia) receive treatment that involves infusing FVIII protein into the bloodstream. However, about 30 percent of them develop an immune response in the form of antibodies to FVIII (inhibitors), rendering treatment ineffective and increasing risk of mortality.
vimarsana © 2020. All Rights Reserved.